VDR and non-small cell lung carcinoma: Another study performed in Caucasian patients (294 cases) (from the United States) diagnosed with advanced non-small-cell lung cancer (NSCLC) showed that carriers of the VDR rs2228570 (FokI)-AA and AG genotypes had a higher risk of death (p = 0.040, HR = 1.32, 95% CI = 0.98–1.77; AG vs. GG and p = 0.04, HR = 1.41, 95% CI = 0.96–2.07; AA vs. GG) [35].